Copanlisib population pharmacokinetics from phase I–III studies and exposure–response relationships in combination with rituximab.

Autor: Morcos, Peter N.1 (AUTHOR) peter.n.morcos@gmail.com, Moss, Jonathan2 (AUTHOR), Austin, Rupert2 (AUTHOR), Hiemeyer, Florian3 (AUTHOR), Zinzani, Pier Luigi4,5 (AUTHOR), Beckert, Vita3 (AUTHOR), Mongay Soler, Lidia1 (AUTHOR), Childs, Barrett H.1 (AUTHOR), Garmann, Dirk3 (AUTHOR)
Zdroj: CPT: Pharmacometrics & Systems Pharmacology. Nov2023, Vol. 12 Issue 11, p1666-1686. 21p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje